Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Biomarkers for early detection of Alzheimer pathology.

Clark CM, Davatzikos C, Borthakur A, Newberg A, Leight S, Lee VM, Trojanowski JQ.

Neurosignals. 2008;16(1):11-8. Review.

2.

The Alzheimer's Disease Neuroimaging Initiative: a review of papers published since its inception.

Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC, Harvey D, Jack CR, Jagust W, Liu E, Morris JC, Petersen RC, Saykin AJ, Schmidt ME, Shaw L, Siuciak JA, Soares H, Toga AW, Trojanowski JQ; Alzheimer’s Disease Neuroimaging Initiative..

Alzheimers Dement. 2012 Feb;8(1 Suppl):S1-68. doi: 10.1016/j.jalz.2011.09.172. Review.

3.

Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.

Hampel H, Bürger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K.

Alzheimers Dement. 2008 Jan;4(1):38-48. doi: 10.1016/j.jalz.2007.08.006. Review.

PMID:
18631949
4.

Biomarkers in the Diagnosis and Prognosis of Alzheimer's Disease.

Schaffer C, Sarad N, DeCrumpe A, Goswami D, Herrmann S, Morales J, Patel P, Osborne J.

J Lab Autom. 2015 Oct;20(5):589-600. doi: 10.1177/2211068214559979. Review.

PMID:
25424384
5.

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease.

Lista S, Garaci FG, Ewers M, Teipel S, Zetterberg H, Blennow K, Hampel H.

Alzheimers Dement. 2014 May;10(3):381-92. doi: 10.1016/j.jalz.2013.04.506. Review.

PMID:
23850330
6.

Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementia.

Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, Walton J, Desai M, Solomon DF, Molena E, Worrall R, Hayen A, Choudhary P, Ladds E, Lanctôt KL, Verhey FR, McCleery JM, Mead GE, Clare L, Fioravanti M, Hyde C, Marcus S, McShane R.

Alzheimers Dement. 2013 May;9(3):e96-e105. doi: 10.1016/j.jalz.2012.01.014. Review.

PMID:
23110863
7.

Biomarkers of Alzheimer's disease and mild cognitive impairment: a current perspective.

Lewczuk P, Mroczko B, Fagan A, Kornhuber J.

Adv Med Sci. 2015 Mar;60(1):76-82. doi: 10.1016/j.advms.2014.11.002. Review.

PMID:
25579841
8.

Contribution of neuroimaging to the diagnosis of Alzheimer's disease and vascular dementia.

Román G, Pascual B.

Arch Med Res. 2012 Nov;43(8):671-6. doi: 10.1016/j.arcmed.2012.10.018. Review.

PMID:
23142262
9.

Alzheimer's disease.

Scheltens P, Blennow K, Breteler MM, de Strooper B, Frisoni GB, Salloway S, Van der Flier WM.

Lancet. 2016 Jul 30;388(10043):505-17. doi: 10.1016/S0140-6736(15)01124-1. Review.

PMID:
26921134
10.

[Markers of prodromal Alzheimer's disease].

de Souza LC, Sarazin M, Uspenskaya O, Habert MO, Lamari F, Lehéricy S, Dubois B.

Rev Neurol (Paris). 2012 Nov;168(11):815-24. doi: 10.1016/j.neurol.2012.07.005. Review. French.

PMID:
22944619
11.

Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.

Prvulovic D, Hampel H.

Clin Chem Lab Med. 2011 Mar;49(3):367-74. doi: 10.1515/CCLM.2011.087. Review.

PMID:
21342022
12.

[Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].

Gertz HJ, Kurz A.

Nervenarzt. 2011 Sep;82(9):1151-9. doi: 10.1007/s00115-010-3213-3. Review. German.

PMID:
21221517
13.

[Biological markers in the diagnosis of dementia and Alzheimer's disease].

Meiner Z, Rosenmann H.

Harefuah. 2012 May;151(5):289-93, 318. Review. Hebrew.

PMID:
22844733
14.

Immunological aspects and anti-amyloid strategy for Alzheimer's dementia.

Liščić RM.

Arh Hig Rada Toksikol. 2013 Dec;64(4):603-8. doi: 10.2478/10004-1254-64-2013-2414. Review.

PMID:
24384767
15.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
16.

The development of effective biomarkers for Alzheimer's disease: a review.

Henry MS, Passmore AP, Todd S, McGuinness B, Craig D, Johnston JA.

Int J Geriatr Psychiatry. 2013 Apr;28(4):331-40. doi: 10.1002/gps.3829. Review.

PMID:
22674539
17.

Clinical indications for analysis of Alzheimer's disease CSF biomarkers.

Engelborghs S.

Rev Neurol (Paris). 2013 Oct;169(10):709-14. doi: 10.1016/j.neurol.2013.07.024. Review.

PMID:
24016466
18.

Alliance for aging research AD biomarkers work group: structural MRI.

Jack CR Jr.

Neurobiol Aging. 2011 Dec;32 Suppl 1:S48-57. doi: 10.1016/j.neurobiolaging.2011.09.011. Review.

19.

Seven-Tesla MRI and neuroimaging biomarkers for Alzheimer's disease.

Ali R, Goubran M, Choudhri O, Zeineh MM.

Neurosurg Focus. 2015 Nov;39(5):E4. doi: 10.3171/2015.9.FOCUS15326. Review.

PMID:
26646928
20.

Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.

Thal DR, Attems J, Ewers M.

J Alzheimers Dis. 2014;42 Suppl 4:S421-9. doi: 10.3233/JAD-141461. Review.

PMID:
25227313

Supplemental Content

Support Center